| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/10/2003 | WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/10/2003 | WO2001098248A3 Hiv integrase inhibitors |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130521 Enantioselective reduction to produce an optically active hydroxyethylpyridine derivative; further derivatized to an intermediate such as a dihydroxyethylpyridine derivative; use of microorganism derived carbonyl-reducing enzymes |
| 07/10/2003 | US20030130520 Producing substituted 2-nitro-guanidine derivatives. |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130488 An asymmetric catalyst that can epoxidize unsaturated amides or ketones |
| 07/10/2003 | US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride |
| 07/10/2003 | US20030130338 Method of treatment |
| 07/10/2003 | US20030130335 Protein tyrosine phosphatases inhibitors |
| 07/10/2003 | US20030130328 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/10/2003 | US20030130309 Antiinflammatory agents; rheumatic diseases |
| 07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
| 07/10/2003 | US20030130285 Controlling cell differentiation, cell proliferation |
| 07/10/2003 | US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130270 Heterocyclic derivatives and their use as antithrombotic agents |
| 07/10/2003 | US20030130265 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
| 07/10/2003 | US20030130259 Quinoline and quinazoline compounds useful in therapy |
| 07/10/2003 | US20030130253 Central nervous system disorders; skin disorders; appetite suppressants |
| 07/10/2003 | US20030130251 Blocking amyloid deposits; Alzheimer's disease, Down syndrome |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130234 Novel indolinones and uses thereof |
| 07/10/2003 | US20030130125 Pesticides; herbicides |
| 07/10/2003 | US20030129552 Color photothermography |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/09/2003 | EP1325921A2 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
| 07/09/2003 | EP1325913A2 Piperidinecarboxylic acid amide derivatives |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/09/2003 | EP1324993A2 Substituted 1,4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP1165496B1 Substituted aniline compounds |
| 07/09/2003 | EP0973768B1 Azole compounds, their production and their use |
| 07/09/2003 | EP0906292B1 Triazolyl mercaptides and their use as microbicides |
| 07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
| 07/09/2003 | EP0900208B1 Acyl mercapto-triazolyl derivatives and the use thereof as microbicides |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | CN1429225A C10 carbonate substituted taxanes as antitumor agents |
| 07/09/2003 | CN1429223A Novel benzofuran derivatives |
| 07/09/2003 | CN1429221A 2-phenylpyran-4-one derivatives |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429196A Process for preparation of aniline compounds |
| 07/09/2003 | CN1428340A 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/09/2003 | CN1113867C Amino anthracyclinone derivatives and their use in treatment of amyloidosis |
| 07/09/2003 | CN1113650C Drug composition of self-emulsifying agent form lipophilic compounds |
| 07/08/2003 | US6589984 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as |
| 07/08/2003 | US6589983 Antiarrhythmic agents having the prolongation effect on the functional refractory period as a main function |
| 07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 07/08/2003 | US6589968 Epothilone compounds and methods for making and using the same |
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/08/2003 | US6589962 Certain alpha -hydroxy- gamma -(((carbocyclic- or heterocyclic- substituted)amino)carbonyl)alkanamide derivatives are described as inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in |
| 07/08/2003 | US6589951 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/08/2003 | US6589736 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053948A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053938A1 Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053437A1 Triazoles as oxytocin antagonists |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | WO2003053331A2 Protease inhibitors |
| 07/03/2003 | WO2002062295A3 Pyridine-substituted benzanilides as potassium ion channel openers |
| 07/03/2003 | WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 07/03/2003 | US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder |
| 07/03/2003 | US20030125562 Functionalized 4-imino-3-mercapto-1,2,4-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth |
| 07/03/2003 | US20030125560 Treating an N-formyl paroxetine compound with a de-formylation agent selected from hydrochloric acid, acetic acid, formic acid, methane sulfonic acid, maleic acid, and tartaric acid forms a salt of paroxetine |
| 07/03/2003 | US20030125558 5-bromosalicylaldehyde is reacted in a one-pot reaction firstly with haloaceticalkyl or benzylester and then with formamide to give 5-L-benzofuran-2-carboxamide, then transition metal-catalyzed ammination with piperazines |
| 07/03/2003 | US20030125370 Treating or preventing protein kinase related disorders in a organism, such as cancer, diabetes, autoimmune disoders, hyperproliferation diosrders, osteoarthritis, rhematoid arthritis, angiogenesis, immunological disorders |
| 07/03/2003 | US20030125369 New indenoindolone compounds |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125367 Administering a patient with bacterial infections a oxazolidinones having a bicylcic/3.1.0/ hexane containing group as antibiotic |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125338 Compounds, compositions and methods for modulating beta-amyloid production |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125320 Seratonin reuptake inhibitors potently binding to the 5-HT1A receptor, dopaminergic agents; antidepressants, psychosis, anxiolytic and antiischemic agents; panic order; obsessive compulsive disorder, impulse control disorder, alcohol abuse |
| 07/03/2003 | US20030125305 Treating patients who have become resistant to a Brc-Abl tyrosine kinase inhibitor, e.g., imatinib mesylate, with a nucleoside analog of a 2-cytosinyl-1,3-dioxolane; chronic myelogenous leukemia in blastic phase; anticarcinogenic agents |
| 07/03/2003 | US20030124053 Radiopharmaceuticals for imaging infection and inflammation |
| 07/03/2003 | US20030121113 Oxobenzofuranylide-dihydroindolone |